FGF2 and cancer: BCAM-induced proteins, previously reported to drive EMT and associated processes such as cell migration in various cancers, include AREG [61], CXCL1 [62], CXCL10 [63], EDN1 [64], FGF2 [65], TGFβ1 [66] and VEGFB [67].